Adaptive Biotechnologies (ADPT) Preferred Stock Liabilities (2018 - 2019)

Adaptive Biotechnologies (ADPT) posted Preferred Stock Liabilities of $561.9 million for Q2 2019, little changed sequentially from $561.2 million in Q1 2019, and little changed YoY from $560.7 million in Q2 2018.

Adaptive Biotechnologies (ADPT) Preferred Stock Liabilities (2018 - 2019) Analysis & Trends

Adaptive Biotechnologies has reported Preferred Stock Liabilities for 2 years, with the latest figure at $561.9 million in Q2 2019.

  • Quarterly Preferred Stock Liabilities changed 0.23% year-over-year to $561.9 million in Q2 2019, while the trailing twelve-month figure through Jun 2019 was $561.9 million (changed 0.23% YoY) and the FY2018 annual result came in at $560.9 million, changed 0.08% from the prior year.
  • Preferred Stock Liabilities was little changed at $561.9 million in Q2 2019 per ADPT's latest filing, from $561.2 million in the prior quarter.
  • Over five years, Preferred Stock Liabilities peaked at $561.9 million in Q2 2019 and troughed at $560.7 million in Q2 2018.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Thermo Fisher Scientific 213.44 Bn 209.37 Bn 8.34 Bn -
2 Danaher 139.95 Bn 135.60 Bn 3.61 Bn -
3 Idexx Laboratories 46.16 Bn 45.96 Bn 779.09 Mn -
4 Agilent Technologies 39.67 Bn 37.87 Bn 990.00 Mn -
5 Iqvia Holdings 39.29 Bn 37.21 Bn 1.44 Bn -
6 Natera 38.61 Bn 37.51 Bn 696.04 Mn -
7 Illumina 29.99 Bn 28.82 Bn 770.00 Mn -
8 Mettler Toledo International 28.57 Bn 28.51 Bn 650.22 Mn -
9 Quest Diagnostics 26.17 Bn 25.55 Bn 1.03 Bn -
10 Adaptive Biotechnologies 3.78 Bn 3.56 Bn 52.17 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2019 561.93 Mn
Mar 31, 2019 561.21 Mn
Dec 31, 2018 560.86 Mn
Sep 30, 2018 560.67 Mn
Jun 30, 2018 560.67 Mn